Welcome to our dedicated page for First Trust/abrdn Global Oppos Income news (Ticker: FAM), a resource for investors and traders seeking the latest updates and insights on First Trust/abrdn Global Oppos Income stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect First Trust/abrdn Global Oppos Income's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of First Trust/abrdn Global Oppos Income's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
First Trust/Aberdeen Global Opportunity Income Fund (FAM) and First Trust/Aberdeen Emerging Opportunity Fund (FEO) announced updates to their investment policies. Each Fund can now invest up to 10% of Managed Assets in forward foreign exchange contracts to hedge or gain exposure to foreign currencies. The remaining policies, including a cap of 5% in non-deliverable contracts, will remain unchanged. These changes are expected to be implemented on or around May 24, 2021. FAM aims for high current income, while FEO focuses on total return.
Summary not available.
First Trust/Aberdeen Global Opportunity Income Fund (NYSE: FAM) announced the final results of its oversubscribed tender offer for up to 20% of its outstanding common shares. The offer, which closed on February 12, 2021, will purchase 2,534,207 shares at $10.7604 each, reflecting 98% of the net asset value (NAV) as of February 16, 2021. Due to high demand, shares will be bought on a pro-rata basis with a pro-ration factor of 46.50%. Post-offer, the total outstanding shares will be 10,136,829. Shareholders can contact Georgeson LLC for inquiries.
First Trust/Aberdeen Global Opportunity Income Fund (NYSE: FAM) has announced preliminary results of its recent tender offer, which sought to buy back up to 20% of its outstanding shares at 98% of net asset value. The offer, which closed on February 12, 2021, was oversubscribed, with 5,450,859 shares tendered. Consequently, purchases will occur on a pro-rata basis among shareholders. The final results are set to be released on February 16, 2021. The Fund aims to provide high current income and capital appreciation through investments in global bond markets.